Rxcurve
HCPCS J7354 · per Per 3.2 mg single-use applicator

Cantharidin top, applicator

Products billed under this code include Ycanth.

Payment limit per Per 3.2 mg single-use applicator, by effective quarter, 3Q24 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J7354

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Ycanth Verrica Pharmaceuticals, Inc. 71349-0070-06 6 $4,100.832
Ycanth Verrica Pharmaceuticals, Inc. 71349-0070-11 1 $683.472

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $683.472 −$11.736 Per 3.2 mg single-use applicator Cantharidin top, applicator v1, posted September 17, 2026
3Q26 $695.208 +$28.135 Per 3.2 mg single-use applicator Cantharidin top, applicator v1, posted September 15, 2026
2Q26 $667.073 +$10.574 Per 3.2 mg single-use applicator Cantharidin top, applicator v1, posted September 15, 2026
1Q26 $656.499 +$1.742 Per 3.2 mg single-use applicator Cantharidin top, applicator v1, posted September 15, 2026
4Q25 $654.757 −$14.837 Per 3.2 mg single-use applicator Cantharidin top, applicator v1, posted September 8, 2026
3Q25 $669.594 −$12.663 Per 3.2 mg single-use applicator Cantharidin top, applicator v1, posted March 10, 2026
2Q25 $682.257 −$29.496 Per 3.2 mg single-use applicator Cantharidin top, applicator v1, posted March 10, 2026
1Q25 $711.753 $0.00 Per 3.2 mg single-use applicator Cantharidin top, applicator v1, posted December 19, 2025
4Q24 $711.753 −$7.831 Per 3.2 mg single-use applicator Cantharidin top, applicator v1, posted June 11, 2025
3Q24 $719.584 – Per 3.2 mg single-use applicator Cantharidin top, applicator v1, posted June 11, 2025

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files